46 related articles for article (PubMed ID: 38541089)
1. Study on the relationship between lipoprotein (a) and diabetic kidney disease.
Wang A; Zhang S; Li Y; Zhu F; Xie B
J Diabetes Complications; 2023 Jan; 37(1):108378. PubMed ID: 36549039
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of nonsteroidal mineralocorticoid receptor antagonists in patients with diabetic kidney disease.
Lerma E; White WB; Bakris G
Postgrad Med; 2023 Apr; 135(3):224-233. PubMed ID: 35392754
[TBL] [Abstract][Full Text] [Related]
3. Urinary Post-Translationally Modified Fetuin-A (uPTM-FetA) in Chronic Kidney Disease Patients with and without Diabetic Kidney Disease.
Musolino M; Greco M; D'Agostino M; Tripodi L; Misiti R; Dragone F; Cianfrone P; Zicarelli M; Foti DP; Andreucci M; Bolignano D; Coppolino G
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541089
[No Abstract] [Full Text] [Related]
4. Urinary Post-Translationally Modified Fetuin-A Protein Is Associated with Increased Risk of Graft Failure in Kidney Transplant Recipients.
Alkaff FF; Kremer D; Te Velde-Keyzer CA; van den Born J; Berger SP; Laverman GD; Chuang LM; Tseng TL; Bakker SJL
Am J Nephrol; 2024; 55(2):225-234. PubMed ID: 37931608
[TBL] [Abstract][Full Text] [Related]
5. Analysis of urine Raman spectra differences from patients with diabetes mellitus and renal pathologies.
Kavuru V; Senger RS; Robertson JL; Choudhury D
PeerJ; 2023; 11():e14879. PubMed ID: 36874959
[TBL] [Abstract][Full Text] [Related]
6. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
[TBL] [Abstract][Full Text] [Related]
7. Utilization of the corticomedullary difference in magnetic resonance imaging-derived apparent diffusion coefficient for noninvasive assessment of chronic kidney disease in type 2 diabetes.
Duan S; Geng L; Lu F; Chen C; Jiang L; Chen S; Zhang C; Huang Z; Zeng M; Sun B; Zhang B; Mao H; Xing C; Zhang Y; Yuan Y
Diabetes Metab Syndr; 2024 Feb; 18(2):102963. PubMed ID: 38373384
[TBL] [Abstract][Full Text] [Related]
8. Urinary Fetuin-A Fragments Predict Progressive Estimated Glomerular Filtration Rate Decline in Two Independent Type 2 Diabetes Cohorts of Different Ethnicities.
Chuang GT; Kremer D; Huang CH; Alkaff FF; Lin CH; Tseng TL; Laverman GD; Bakker SJL; Chuang LM
Am J Nephrol; 2024; 55(1):106-114. PubMed ID: 37812932
[TBL] [Abstract][Full Text] [Related]
9. Increased Risk of Cardiovascular Complications in Chronic Kidney Disease: Introduction to a Compendium.
Noels H; Jankowski J
Circ Res; 2023 Apr; 132(8):899-901. PubMed ID: 37053281
[No Abstract] [Full Text] [Related]
10. Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).
de Boer IH; Khunti K; Sadusky T; Tuttle KR; Neumiller JJ; Rhee CM; Rosas SE; Rossing P; Bakris G
Diabetes Care; 2022 Dec; 45(12):3075-3090. PubMed ID: 36189689
[TBL] [Abstract][Full Text] [Related]
11. The structure, biosynthesis, and biological roles of fetuin-A: A review.
Chekol Abebe E; Tilahun Muche Z; Behaile T/Mariam A; Mengie Ayele T; Mekonnen Agidew M; Teshome Azezew M; Abebe Zewde E; Asmamaw Dejenie T; Asmamaw Mengstie M
Front Cell Dev Biol; 2022; 10():945287. PubMed ID: 35923855
[TBL] [Abstract][Full Text] [Related]
12. Urinary fetuin-A peptides as a new marker for impaired kidney function in patients with type 2 diabetes.
Magalhães P; Zürbig P; Mischak H; Schleicher E
Clin Kidney J; 2021 Jan; 14(1):269-276. PubMed ID: 33564428
[TBL] [Abstract][Full Text] [Related]
13. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD Chronic Kidney Disease Collaboration
Lancet; 2020 Feb; 395(10225):709-733. PubMed ID: 32061315
[TBL] [Abstract][Full Text] [Related]
14. The global burden of chronic kidney disease.
Cockwell P; Fisher LA
Lancet; 2020 Feb; 395(10225):662-664. PubMed ID: 32061314
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
